ArticleInternational medical case reports journal2026
Male Systemic Lupus Erythematosus: A Rare Case of Multisystem Involvement.
Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations. Although SLE predominantly affects women, male patients may present atypically, leading to diagnostic challenges and delays in treatment. Neuropsychiatric involvement and lupus nephritis represent severe manifestations associated with increased morbidity. Case Presentation: A 31-year-old man presented with fatigue, joint pain, fever, and a photosensitive skin rash. Laboratory investigations showed positive antinuclear antibodies and elevated anti-double-stranded DNA levels. Brain MRI demonstrated scattered T2-weighted and FLAIR hyperintensities suggestive of central nervous system vasculitis, while renal biopsy confirmed class IV lupus nephritis. The patient was treated with corticosteroids, hydroxychloroquine, and mycophenolate mofetil. Follow-up MRI and MRA performed after three weeks showed partial resolution of white matter lesions with stable vasculature. Clinical symptoms improved, and renal function stabilised. Conclusion: This case highlights the importance of considering neuropsychiatric SLE in male patients presenting with neurological symptoms and multisystem involvement. MRI and MRA can play an important role in detecting central nervous system involvement and monitoring treatment response, while early recognition and prompt treatment may help prevent irreversible neurological complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.